Insight Survey - South African nasal allergy market grows as combination, preservative-free and drug-free sprays gain traction

Recent developments are extending beyond conventional decongestant sprays to include combination therapies, preservative-free and saline-based products, and drug-free barrier technologies designed to reduce contact between airborne allergens and the nasal lining.

Insight Survey’s latest South African Allergy Care Market Sizing and Competitor Analysis Insights Report 2026 carefully unfolds the local allergy care market based on credible industry intelligence and research. The report examines the South African allergy care industry through a focused competitor intelligence lens, including market sizing, manufacturer and distributor activity, retail analysis, product ranges, and company news.

Globally, the allergy care market continues to demonstrate strong growth, with the market valued at approximately $24.75bn in 2025 and forecast to reach approximately $52.61bn by 2034, growing at a compound annual growth rate (CAGR) of approximately 8.7%. This growth is being supported by the rising prevalence of allergic conditions and increasing awareness of self-medication as consumers increasingly make use of over-the-counter treatments such as antihistamines.

In South Africa, the local allergy care market has also experienced strong growth, increasing by 8.0% CAGR between 2020 and 2025. Looking ahead, the market is forecast to grow at a CAGR of approximately 7.0% between 2025 and 2030.

Recent developments indicate that nasal delivery is becoming increasingly differentiated within the global allergy care landscape. For example, Glenmark received US FDA approval to expand the use of its RYALTRIS® combination nasal spray to children aged six to under 12 years with seasonal allergic rhinitis. Similarly, the United Kingdom’s Medicines and Healthcare products Regulatory Agency approved the reclassification of Pirinase Allergy Nasal Spray for adolescents aged 12 years and older. The approval enabled the product to be supplied through pharmacies without a prescription, making it the first intranasal corticosteroid to be supplied by pharmacists to this age group in Europe.

Innovation is also extending beyond traditional medicated formulations. Altamira Medica received European Medical Device Regulation certification for Bentrio®, a drug-free and preservative-free nasal spray that forms a protective gel layer over the nasal mucosa to help reduce contact with airborne allergens.

Within South Africa, the importance of nasal treatments within the allergy care landscape is also reflected in pharmacy-based consumer education. For example, Clicks has highlighted intranasal corticosteroid sprays as an important treatment option for nasal hay fever symptoms, while also recognising the role of saline nasal sprays and irrigation in removing pollen and nasal secretions.

Saline and natural seawater nasal formats are similarly maintaining a visible presence across local pharmacy channels. For example, Dis-Chem promoted the Stérimar range at a 15% discount, positioning the products around relief from blocked noses and allergy flare-ups.

The South African Allergy Care Market Sizing and Competitor Analysis Insights Report 2026 (53 pages) provides a dynamic synthesis of industry research, examining the local allergy care industry, with an in-depth view of manufacturers, distributors, retailers, product ranges, latest company news, marketing initiatives, social media following, brand positioning and competitor strategy.

The report also forms part of Insight Survey’s refreshed ‘build-your-own’ Industry Insights Report offering. Clients can now choose from ready-to-buy reports or build their own customised report based on their research needs and budget. In addition to the ready-to-buy SA Market Sizing and Competitor Analysis Insights Report, clients can request on-demand Global Industry Insights, South African Industry Insights, Pricing Analysis, Survey Insights, Quarterly Industry Intelligence, or a Full Landscape Insights Report.

Some key questions the report will help you to answer

• What are the current market dynamics of the South African Allergy Care industry, including market size and forecast growth?
• How has the South African Allergy Care performed between 2020 and 2025, and how is it forecast to grow between 2026 and 2030?
• Which are the key manufacturers, distributors, and retail players in the South African allergy care industry?
• What is the latest company news for key players in terms of products, new launches, and marketing initiatives?

You can view more information about the report and order online here: South African Allergy Care Industry Insights Report 2026.

For more information, please email az.oc.yevrusthgisni@ofni, call our Cape Town office on (021) 045-0202, or Johannesburg office on (010) 140-5756.

About Insight Survey:

Insight Survey is a South African B2B market research company with more than 15 years of heritage, focusing on business-to-business (B2B) and industry research to ensure smarter, more-profitable business decisions are made with reduced investment risk.

We offer market research solutions to help you to successfully improve or expand your business, enter new markets, launch new products or better understand your internal or external environment.

Our bespoke Competitive Business Intelligence Research can help give you the edge in a global marketplace, empowering your business to overcome industry challenges quickly and effectively, and enabling you to realise your potential and achieve your vision.

From strategic overviews of your business’s competitive environment through to specific competitor profiles, our customised Competitive Intelligence Research is designed to meet your unique needs.

For more information, go to www.insightsurvey.co.za